Tag Archive for PRO/AH/EDR> Ebola update (03): Ebanga monoclonal antibody
PRO/AH/EDR> Ebola update (03): Ebanga monoclonal antibody
Ebola -- Worldwide/UnknownBiotechnology company, Ridgeback Biotherapeutics, announced recently that the U.S. Food and Drug Administration (FDA) approved EbangaTM for the treatment of Ebola.Ebanga is now approved for treatment of infection caused by _Zaire ebolavirus_ in adult and pediatric patients (including neonates born to a mother who is RT-PCR positive for _Zaire ebolavirus_ infection).Ebanga is the only FDA approved, single injection Ebola treatment which is available in a lyophilized form.Ebanga Read more [...]
